GCGuillaume Caron

Guillaume Caron

*This is an algorithmically generated author record based on publicly available information.

Guillaume Caron has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Motoneurons Inhibitory Synapses Homeostatically Respond to Neuronal Activity and Modulate Amyotrophic Lateral Sclerosis Pathogenesis

    by Kareen Halablab, Gizem Yartas, Natalie Dikwella, Oumayma Aousji, Burak Ozkan, Cedric Jan, Diana Wiesner, Simon M. Danner, Guillaume Caron, Daniel Zytnicki, et al.

    Alterations in excitation/inhibition (E/I) balance and changes in motor neurons (MN) activity may contribute to MN vulnerability in ALS. The balance of pathogenic versus adaptive changes occurring in inhibitory synapses and affecting E/I balance remain unclear. Confocal microscopy of MN from P45 male SOD1G93A mice reveal downregulated GlyR but upregulated GABAR clusters at inhibitory synapses. GlyR and GABAR respond to PSAM and DREADD chemogenetic alterations of MN excitability, with increased activity driving increase in inhibitory clusters. An E3 ligase-conjugated intrabody (GFE3) degrades Gephyrin, decreases GABAR and GlyR clusters, increases net activity, and downregulates disease markers. However, simultaneous decrease of inhibition and increased activity by actPSAM and GFE3 shows no net beneficial effects on disease markers. Thus inhibitory synapses are involved in the early phases of ALS pathogenesis and respond to persistent homeostatic loops, and their suppression delivers a net activity increase, offering potential benefits on disease pathways.


  • Open Access

    Spinal motoneuron excitability is homeostatically regulated through β-adrenergic neuromodulation in wild-type and presymptomatic SOD1 mice

    by Stefano Antonucci, Guillaume Caron, Natalie Dikwella, Sruthi Sankari Krishnamurthy, Anthony Harster, Bartosz Wasicki, Hina Zarrin, Aboud Tahanis, Florian Olde Heuvel, Simon M. Danner, et al.


  • Open Access

    KCC2 enhancers normalize reflex responses and improve locomotor function after chronic spinal cord injury

    by Jadwiga N. Bilchak, Simon M. Danner, Guillaume Caron, Marie‐Pascale Côté

    Within a year after a spinal cord injury (SCI), 75% of individuals develop spasticity. While normal movement relies on the ability to adjust reflexes appropriately, and on reciprocal inhibition of antagonistic muscles, spastic individuals display hyperactive spinal reflexes and involuntary muscle co‐contractions. Current anti‐spastic medications can suppress uncontrolled movements, but by acting on GABAergic signalling, these medications lead to severe side‐effects and weakened muscle force, making them incompatible with activity‐based therapies. We have previously shown that pharmacologically enhancing activity of KCC2, a chloride cotransporter, reduces signs of spasticity in anaesthetized chronic SCI rats. Here, we examine the effect of enhancing KCC2 in awake animals, using a battery of tests assessing hyperreflexia in multiple reflex pathways required for normal movement as well as locomotor function. Sprague‐Dawley rats were implanted with chronic EMG electrodes bilaterally in ankle flexor and ankle extensor muscles and received a complete spinal transection at T12. Four weeks following SCI, the stretch reflex, the non‐nociceptive cutaneous reflex pathway, the flexor withdrawal reflex and the crossed‐extensor reflex pathway as well as locomotor function were evaluated before and after receiving the KCC2 enhancer, CLP290. Our results show that enhancing KCC2 activity normalizes reflex responses in multiple pathways and reduces muscle co‐contraction without weakening motor output, thereby improving stepping ability. This work reveals the substantial potential for KCC2 enhancers as a novel anti‐spastic treatment. image Key points: After chronic spinal cord injury (SCI), the dysregulation of chloride homeostasis and subsequent decrease in spinal inhibition contributes to the development of spastic symptoms. We previously showed that enhancing the activity of the chloride co‐transporter KCC2 after SCI decreases electrophysiological correlates of hyperreflexia and spasticity in deeply anaesthetized animals. Here, we examine the effect of enhancing KCC2 activity in awake animals on the excitability of multiple spinal reflex pathways required for normal movement including locomotion. We show that CLP290 decreases hyperreflexia, and reduces muscle co‐contraction without weakening motor output, thereby improving stepping ability. Our results suggest that KCC2 enhancers such as CLP290 have the potential to be used as an anti‐spastic treatment after SCI.


  • Open Access

    Exercise-Induced Plasticity in Signaling Pathways Involved in Motor Recovery after Spinal Cord Injury

    by Jadwiga N. Bilchak, Guillaume Caron, Marie-Pascale Côté

    Spinal cord injury (SCI) leads to numerous chronic and debilitating functional deficits that greatly affect quality of life. While many pharmacological interventions have been explored, the current unsurpassed therapy for most SCI sequalae is exercise. Exercise has an expansive influence on peripheral health and function, and by activating the relevant neural pathways, exercise also ameliorates numerous disorders of the central nervous system (CNS). While the exact mechanisms by which this occurs are still being delineated, major strides have been made in the past decade to understand the molecular underpinnings of this essential treatment. Exercise rapidly and prominently affects dendritic sprouting, synaptic connections, neurotransmitter production and regulation, and ionic homeostasis, with recent literature implicating an exercise-induced increase in neurotrophins as the cornerstone that binds many of these effects together. The field encompasses vast complexity, and as the data accumulate, disentangling these molecular pathways and how they interact will facilitate the optimization of intervention strategies and improve quality of life for individuals affected by SCI. This review describes the known molecular effects of exercise and how they alter the CNS to pacify the injury environment, increase neuronal survival and regeneration, restore normal neural excitability, create new functional circuits, and ultimately improve motor function following SCI.